Charles LeVea

2.3k total citations
71 papers, 1.8k citations indexed

About

Charles LeVea is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Charles LeVea has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 27 papers in Surgery and 24 papers in Molecular Biology. Recurrent topics in Charles LeVea's work include Gastric Cancer Management and Outcomes (15 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Esophageal Cancer Research and Treatment (11 papers). Charles LeVea is often cited by papers focused on Gastric Cancer Management and Outcomes (15 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Esophageal Cancer Research and Treatment (11 papers). Charles LeVea collaborates with scholars based in United States and Türkiye. Charles LeVea's co-authors include Mark I. Greene, Xiaolan Qian, William C. Dougall, Valerie I. Brown, Jeffrey N. Myers, Takuro Wada, Renuka Iyer, Yasuo Kokai, Kunio Dobashi and James G. Davis and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Charles LeVea

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles LeVea United States 24 997 720 397 326 321 71 1.8k
Niranjan Awasthi United States 25 703 0.7× 889 1.2× 211 0.5× 191 0.6× 294 0.9× 65 1.9k
E. Ioachim Greece 24 492 0.5× 674 0.9× 375 0.9× 269 0.8× 171 0.5× 79 1.7k
Shi‐Ming Tu United States 19 781 0.8× 857 1.2× 361 0.9× 206 0.6× 1.1k 3.4× 72 2.1k
Yong Tang China 17 791 0.8× 629 0.9× 233 0.6× 365 1.1× 503 1.6× 65 1.7k
Maria Matsangou United States 16 804 0.8× 631 0.9× 703 1.8× 113 0.3× 419 1.3× 42 1.8k
Stefania Marsili Italy 22 732 0.7× 386 0.5× 239 0.6× 105 0.3× 388 1.2× 55 1.5k
Chun‐Ming Huang Taiwan 23 796 0.8× 485 0.7× 502 1.3× 157 0.5× 308 1.0× 58 1.7k
Vladimir Bilim Japan 25 583 0.6× 1.4k 1.9× 255 0.6× 134 0.4× 475 1.5× 81 2.1k
Jeroen T. Buijs Netherlands 27 1.5k 1.5× 1.5k 2.1× 230 0.6× 286 0.9× 532 1.7× 52 2.9k
Joshua Klopper United States 17 580 0.6× 750 1.0× 470 1.2× 99 0.3× 175 0.5× 34 2.2k

Countries citing papers authored by Charles LeVea

Since Specialization
Citations

This map shows the geographic impact of Charles LeVea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles LeVea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles LeVea more than expected).

Fields of papers citing papers by Charles LeVea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles LeVea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles LeVea. The network helps show where Charles LeVea may publish in the future.

Co-authorship network of co-authors of Charles LeVea

This figure shows the co-authorship network connecting the top 25 collaborators of Charles LeVea. A scholar is included among the top collaborators of Charles LeVea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles LeVea. Charles LeVea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gopalakrishnan, Dharmesh, Rohit Jain, Gissou Azabdaftari, et al.. (2021). Case Report: Immune Checkpoint Inhibitor-Induced Exuberant Tumor Inflammation With Accelerated Clinical Deterioration in Metastatic Renal Cell Carcinoma. Frontiers in Oncology. 11. 679177–679177. 2 indexed citations
2.
Mukherjee, Sarbajit, Venkata K. Pokuri, Boris W. Kuvshinoff, et al.. (2018). Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS ONE. 13(6). e0198809–e0198809. 39 indexed citations
3.
Al‐Sukhni, Eisar, Charles LeVea, Joseph J. Skitzki, John M. Kane, & Valerie Francescutti. (2016). Key gaps in pathologic reporting for appendiceal mucinous neoplasms: time for universal synoptic reporting?. Annals of Diagnostic Pathology. 24. 52–54. 2 indexed citations
4.
Özbilge, Hatice, Charles LeVea, Allen Chung, Qingsheng Li, & Nejat K. Egilmez. (2015). Modulating gut immunity and neoplasia with oral cytokine adjuvants. OncoImmunology. 4(4). e1002724–e1002724. 2 indexed citations
5.
6.
Chen, Weiwei, Rafał Kozielski, Charles LeVea, & Frank Chen. (2012). The Advances in Molecular Biology of Hepatoblastoma: Implications for Diagnostic Pathology. North American Journal of Medicine and Science. 5(4). 217–217. 3 indexed citations
7.
Javle, Milind, Gary Yang, Gregory E. Wilding, et al.. (2009). Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis. Cancer Investigation. 27(2). 193–200. 14 indexed citations
8.
Ongchin, Melanie, Jing Wang, Richard Cheney, et al.. (2009). The Effects of Epidermal Growth Factor Receptor Activation and Attenuation of the TGFβ Pathway in an Orthotopic Model of Colon Cancer. Journal of Surgical Research. 156(2). 250–256. 11 indexed citations
9.
Fakih, Marwan, Gary Yang, Lakshmi Pendyala, et al.. (2008). Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(3). 650–657. 26 indexed citations
10.
Javle, Milind, Renuka Iyer, Gary Yang, et al.. (2008). Pilot Study of Gefitinib, Oxaliplatin, and Radiotherapy for Esophageal Adenocarcinoma. American Journal of Clinical Oncology. 31(4). 329–334. 29 indexed citations
11.
Iyer, Renuka, et al.. (2007). Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer. Oncology. 73(5-6). 281–289. 27 indexed citations
12.
Agrawal, Shefali, Boris W. Kuvshinoff, Thaer Khoury, et al.. (2007). CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 11(4). 445–451. 40 indexed citations
13.
Gupta, Bhavna, Charles LeVea, Alan Litwin, & Marwan Fakih. (2007). Reversible Grade 4 Hyperbilirubinemia in a Patient with UGT1A1 7/7 Genotype Treated with Irinotecan and Cetuximab. Clinical Colorectal Cancer. 6(6). 447–449. 10 indexed citations
14.
Rajput, Ashwani, et al.. (2006). RON tyrosine kinase: a potential target for colorectal cancer therapy. Cancer Research. 66. 633–633. 1 indexed citations
15.
Khoury, Thaer, Milind Javle, Kathleen Donohue, et al.. (2005). Expression of Intestinal Trefoil Factor (TFF-3) in Hepatocellular Carcinoma. International Journal of Gastrointestinal Cancer. 35(3). 171–178. 25 indexed citations
16.
Javle, Milind, Dongfeng Tan, Jihnhee Yu, et al.. (2004). Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.. PubMed. 51(60). 1653–7. 23 indexed citations
17.
LeVea, Charles & Robert A. Mooney. (2003). The Leukocyte Common Antigen-Related Protein LAR: Candidate PTP for Inhibitory Targeting. Current Topics in Medicinal Chemistry. 3(7). 809–819. 22 indexed citations
18.
LeVea, Charles, et al.. (1992). Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.. PubMed. 2(1). 1–16. 12 indexed citations
19.
Wada, Takuro, Jeffrey N. Myers, Y Kokai, et al.. (1990). Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.. PubMed. 5(4). 489–95. 31 indexed citations
20.
Kokai, Yasuo, Jeffrey N. Myers, Takuro Wada, et al.. (1989). Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell. 58(2). 287–292. 281 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niranjan Awasthi Breakdown of academic impact, for papers by E. Ioachim Breakdown of academic impact, for papers by Shi‐Ming Tu Breakdown of academic impact, for papers by Yong Tang Breakdown of academic impact, for papers by Maria Matsangou Breakdown of academic impact, for papers by Stefania Marsili Breakdown of academic impact, for papers by Chun‐Ming Huang Breakdown of academic impact, for papers by Vladimir Bilim Breakdown of academic impact, for papers by Jeroen T. Buijs Breakdown of academic impact, for papers by Joshua Klopper
Rankless by CCL
2026